Monday 14 October, 2019
Edition: English (US)
MMJ Observer
Tag Archives: GW Pharmaceuticals plc

GW Pharmaceuticals Plc (OTCMKTS:GWPRF) clocked weekly gains of 10% on reporting impressive results and on the news of Epidiolex, a famed drug. It beat the analysts’ expectations and posted better than expected results in the latest quarter. Impressive...

By Elizabeth Jackson on May 16th, 2019

Marapharm Ventures Inc (OTCMKTS:MRPHF) has signed a letter of intent to take over Full Spectrum Medicinal Inc. The company has set September 30, 2018, as the deadline to conduct due diligence on Full Spectrum and complete the acquisition. Following...

By Jaime Williams on Jul 5th, 2018
GW Pharmaceuticals

GW Pharmaceuticals Plc (NASDAQ:GWPH) has announced its bringing on board Scott Giacobello to serve in the capacity of the Chief Financial Officer. The company through its cannabinoid product platform has over the years engaged in the discovery,...

By Jaime Williams on Mar 9th, 2017

GW Pharmaceuticals plc (NASDAQ:GWPH) has presented new encouraging data from two Phase 3 clinical trials evaluating Epidiolex (cannabidiol [CBD]) for the treatment of Dravet syndrome and Lennox-Gastaut syndrome (LGS), respectively, at the 70th...

By Emily Gibson on Dec 6th, 2016

Don’t Just Beat the Market, Crush It!

Let’s put the power in your hands. I do the work, find, and reveal up to 10 simple trades each week that can make you a killing. Learn my system. Trade my system. Keep all the profits.
**Limited only for the next 47 visitors
Click Me